Mayo Clinic and Thermo Fisher launch biomedical data group Precure
A new partnership will apply large-scale biomedical data to advance treatments, devices, and diagnostics.
Mayo Clinic has teamed up with Thermo Fisher Scientific to form a new biomedical data group called Precure. The partnership is aimed at harnessing large-scale data in ways that could lead to a better understanding of disease and support the development of new medical products.
The group's stated focus spans treatments, devices, and diagnostics, meaning its work could touch multiple areas of healthcare. By combining Mayo Clinic's clinical expertise with Thermo Fisher's capabilities in data and lab technology, Precure is positioned as an effort to turn biomedical information into practical medical advances.
Because this report is based on a single source, there are no differing accounts to compare. The announcement describes Precure as an early-stage initiative, with details about specific projects and timelines still to emerge.
Sources · 2
More in Medicine & Biotech
Ebola Vaccine Trial Launches in DR Congo Outbreak Zone
Health workers in DR Congo have begun testing whether a vaccine designed for a different Ebola strain can protect against the current outbreak.
Beacon Gene Therapy for Rare Vision Loss Succeeds in Pivotal Trial
A pivotal trial of Beacon Therapeutics' gene therapy for X-linked retinitis pigmentosa improved visual acuity, clearing the path toward an FDA submission.
Alkermes orexin agonist shows early promise for ADHD
Early-stage data suggest Alkermes' orexin agonist could expand the drug class beyond sleep disorders into ADHD.
Telix to Buy ITM for $1.65B, Challenging Novartis in Radiopharma
The acquisition gives Telix a late-stage pipeline and supply network that could compete with Novartis' Lutathera.